LIFECORE BIOMEDICAL INC DE
For the period ended Nov 24, 2024. Filed Jan 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Nov 24, 2024 · Filed Jan 2, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Earnings Per Share
- Earnings Per Share
The following table sets forth the weighted average shares used in the computation of basic and diluted earnings per share:
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| November 24, 2024 | November 26, 2023 | November 24, 2024 | November 26, 2023 | |
| Weighted average shares for basic income or loss per share | 34,360,657 | 30,458,032 | 32,609,808 | 30,430,712 |
| Effect of dilutive securities: | ||||
| Convertible preferred stock | — | 5,790,810 | — | 5,737,685 |
| Stock options, RSUs and PSUs | — | 170,261 | — | 228,955 |
| Weighted average shares for diluted income or loss per share | 34,360,657 | 36,419,103 | 32,609,808 | 36,397,352 |
Due to the Company’s net loss for the three and six months ended November 24, 2024, the diluted income or loss per share is calculated using only the basic weighted average common shares outstanding and thus excludes the following, as such impact would be antidilutive:
| Three Months Ended | Six Months Ended | |
|---|---|---|
| November 24, 2024 | November 24, 2024 | |
| Convertible Preferred Stock | 6,769,985 | 6,707,861 |
| Stock Options | — | — |
| Restricted Stock Units | 237,084 | 209,713 |
| Performance Share Units(1) | 8,500 | 17,000 |
| Total | 7,015,569 | 6,934,574 |
(1) PSUs are not considered dilutive until performance targets are met.
See Note 13 – Convertible Preferred Stock and Common Stock for more information on outstanding Convertible Preferred Stock and Note 12 – Stock-based Compensation for more information on outstanding stock options, RSUs and PSUs.
-8-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.